Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.20.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Assets    
Cash and cash equivalents $ 881,487 $ 6,208
Equity method investments 718,793 498,631
Loans 1,100,000  
Real estate 359,948 362,265
Investments 51,638 74,530
Securitization assets 146,549 123,979
Other assets 86,649 162,054
Total Assets 3,344,498 2,387,274
Liabilities:    
Accounts payable, accrued expenses and other 56,843 54,351
Credit facilities 22,565 31,199
Non-recourse debt 599,958 700,225
Senior unsecured notes 1,278,844 512,153
Convertible notes 288,551 149,434
Total Liabilities 2,246,761 1,447,362
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 74,252,973 and 66,338,120 shares issued and outstanding, respectively 743 663
Additional paid in capital 1,282,744 1,102,303
Accumulated deficit (202,914) (169,786)
Accumulated other comprehensive income (loss) 11,474 3,300
Non-controlling interest 5,690 3,432
Total Stockholders’ Equity 1,097,737 939,912
Total Liabilities and Stockholders’ Equity 3,344,498 2,387,274
Government receivables    
Assets    
Loans 250,914 263,175
Commercial receivables    
Assets    
Loans $ 848,520 $ 896,432